AACE/ACE disease state commentary: Molecular diagnostic testing of thyroid nodules with indeterminate cytopathology

Endocrine Practice

Volumn 20, Issue 4, 2014, Pages 360-363

  Bernet, Victor ^a   Hupart, Kenneth H ^a   Parangi, Sareh ^a   Woeber, Kenneth A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MOLECULAR MARKER; THYROTROPIN RECEPTOR;

ATYPIA OF UNDETERMINED SIGNIFICANCE; BRAF GENE; CANCER RISK; COST EFFECTIVENESS ANALYSIS; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE POSITIVE RESULT; FINE NEEDLE ASPIRATION BIOPSY; FOLLICULAR LESION OF UNDETERMINED SIGNIFICANCE; GENE EXPRESSION; GENE REARRANGEMENT; HUMAN; MOLECULAR DIAGNOSIS; MUTATIONAL ANALYSIS; ONCOGENE RAS; POINT MUTATION; PREDICTIVE VALUE; PROBABILITY; RELIABILITY; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THYROID NODULE; VALIDITY; PATHOLOGY;

BIOPSY, FINE-NEEDLE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; THYROID NODULE;

EID: 84898604201     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP14066.PS     Document Type: Review

References (15)

1. Popoveniuc G, Jonklaas J. Thyroid nodules. Med Clin North Am. 2012;96:329-349.
2. Bongiovanni M, Spitale A, Faquin WC, Baloch ZW. The Bethesda system for reporting thyroid cytopathology: A meta-Analysis. Acta Cytol. 2012;56:333-339.
3. Alexander EK, Kennedy GC, Baloch ZW, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 2012;367:705-715.
4. Walsh PS, Wilde JI, Tom EY, et al. Analytical performance verification of a molecular diagnostic for cytology-indeterminate thyroid nodules. J Clin Endocrinol Metab. 2012;97:E2297-E2306.
5. Nikiforov YE, Steward DL, Robinson-Smith, et al., Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab. 2009;94:2092-2098.
6. Cantara S, Capezzone M, Marchisotta S, et al. Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. J Clin Endocrinol Metab. 2010;95:1365-1369.
7. Nikiforov YE, Ohori NP, Hodak SP, et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: A prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab. 2011;96:3390-3397.
8. Filicori F, Keutgen XM, Buitrago D, et al. Risk stratification of indeterminate thyroid fine-needle aspiration biopsy specimens based on mutation analysis. Surgery. 2011;150: 1085-1091.
9. Duick DS, Klopper JP, Diggans JC, et al. The impact of benign gene expression classifier test results on the endocrinologist-patient decision to operate on patients with thyroid nodules with indeterminate fine-needle aspiration cytopathology. Thyroid. 2012;22:996-1001.
10. Li H, Robinson KA, Anton B, Saldanha IJ, Ladenson PW. Cost-effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules. J Clin Endocrinol Metab. 2011;96:E1719-E1726.
11. Yip L, Farris C, Kabaker AS, et al. Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsies. J Clin Endocrinol Metab. 2012;97: 1905-1912.
12. Cibas ES, Baloch ZW, Fellegara G, et al. A prospective assessment defining the limitations of thyroid nodule pathologic evaluation. Ann Intern Med. 2013;159:325-332.
13. Harrell RM, Bimston DN. Surgical Utility of Afirma: Effects of High Cancer Prevalence and Oncocytic Cell Types in Patients with Indeterminate Thyroid Cytology. Endocr Pract. 2014;20:364-369.
14. Kim MI, Alexander EK. Diagnostic use of molecular markers in the evaluation of thyroid nodules. Endocr Pract. 2012;18:796-802.
15. Ross DS. Diagnostic approach to and treatment of thyroid nodules. In: Cooper DS, ed. UpToDate. Waltham, MA: UpToDate. Available at: Http://www.uptodate.com/contents/diagnostic-Approach-To-And-Treatment-of- Thyroid-nodules. Accessed March 22, 2014.